| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/04/2001 | CA2395408A1 Interferon-like molecules and uses thereof |
| 06/03/2001 | CA2325806A1 Methods for the diagnosis and prognosis of acute leukemias |
| 06/02/2001 | CA2325594A1 Novel nucleotide sequences coding for the gpm gene |
| 06/01/2001 | CA2324787A1 Personal gene library |
| 05/31/2001 | WO2001038879A2 Method, apparatus, media and signals for identifying associated cell signaling proteins |
| 05/31/2001 | WO2001038878A2 Pin1 as a marker for abnormal cell growth |
| 05/31/2001 | WO2001038877A2 Multiblot kinase analysis |
| 05/31/2001 | WO2001038862A1 Cholesterol sensor and method for determining cholesterol |
| 05/31/2001 | WO2001038852A1 Quantitative detection of viruses by light scattering |
| 05/31/2001 | WO2001038587A2 Energy-transfer assay for polynucleic acid polymerases |
| 05/31/2001 | WO2001038586A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/31/2001 | WO2001038585A2 Polymer arrays and methods of using labeled probe molecules to identify and quantify target molecule expression |
| 05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 05/31/2001 | WO2001038583A2 Capillary array-based sample screening |
| 05/31/2001 | WO2001038582A1 CATALYTIC RNAs WITH AMINOACYLATION ACTIVITY |
| 05/31/2001 | WO2001038581A2 Vigilance nucleic acids and related diagnostic, screening and therapeutic methods |
| 05/31/2001 | WO2001038580A2 Nucleic acid probe arrays |
| 05/31/2001 | WO2001038579A2 Method of identifying toxic agents using nsaid-induced differential gene expression in liver |
| 05/31/2001 | WO2001038578A1 Inherited retinal diseases at the canine rp3 locus: linkage, marker- and mutation-based tests |
| 05/31/2001 | WO2001038577A2 Human transcriptomes |
| 05/31/2001 | WO2001038576A2 Human single nucleotide polymorphisms |
| 05/31/2001 | WO2001038574A1 Dna sequencing method which employs various dna polymerases and kit used for the same |
| 05/31/2001 | WO2001038573A1 Dna sequencing method which employs various nucleotide mixtures and kit used for the same |
| 05/31/2001 | WO2001038572A1 Method of amplifying nucleic acids |
| 05/31/2001 | WO2001038571A1 Mismatch-recognizing molecules |
| 05/31/2001 | WO2001038570A1 Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample |
| 05/31/2001 | WO2001038569A1 Methods for detecting polypeptides regulating signal transduction pathways |
| 05/31/2001 | WO2001038568A2 Automated method for identifying related biomolecular sequences |
| 05/31/2001 | WO2001038567A2 Genetic indicators of tobacco consumption |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038565A2 Oligomer array with pna and/or dna oligomers on a surface |
| 05/31/2001 | WO2001038564A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 05/31/2001 | WO2001038563A1 Method for the determination of the concentration of micro-organisms |
| 05/31/2001 | WO2001038561A1 Methods of use of peptide deformylase inhibitors as novel antibacterial agents |
| 05/31/2001 | WO2001038560A2 Active enzyme detection using immobilized enzyme inhibitors |
| 05/31/2001 | WO2001038558A2 Age-corrected mmp-assay for malignant pathologies |
| 05/31/2001 | WO2001038556A1 A self-primed amplification system |
| 05/31/2001 | WO2001038550A2 Methods for altering the expression of hyphal-specific genes |
| 05/31/2001 | WO2001038544A1 Method for purifying proteins |
| 05/31/2001 | WO2001038538A1 Polymerase compositions and methods of use thereof |
| 05/31/2001 | WO2001038532A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/31/2001 | WO2001038527A1 Novel protein tab2 |
| 05/31/2001 | WO2001038519A1 Novel nucleic acid and polypeptide |
| 05/31/2001 | WO2001038511A2 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/31/2001 | WO2001038509A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038500A2 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 05/31/2001 | WO2001038498A2 A new genotype of hepatitis b virus |
| 05/31/2001 | WO2001038494A1 Method of proliferating natural killer cells |
| 05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038482A1 Hybridization device, case, support, and label agent |
| 05/31/2001 | WO2001038395A1 Oxidized apolipoproteins and methods of use |
| 05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038352A2 Methods of inhibiting metastasis |
| 05/31/2001 | WO2001037958A2 Electrodeless dielectrophoresis for polarizable particles |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037866A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 05/31/2001 | WO2001037864A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037852A2 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | WO2001037779A2 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | WO2001002598A3 Screening for compounds modulating mitochondrial proton leak |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000077229A3 R1 protein from wheat and the use thereof for the production of modified strach |
| 05/31/2001 | WO2000073493A3 A nematode drug screen for modulators of mammalian disorders |
| 05/31/2001 | WO2000072258A3 Method and system for general purpose analysis of experimental data |
| 05/31/2001 | WO2000071748A3 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 05/31/2001 | WO2000068416A3 Method for localising proteases which split substrates that are specifically connected by a membrane |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000056901A3 Linear and circular expression elements |
| 05/31/2001 | WO2000053762A3 Plant disease resistance associated genes and uses thereof |
| 05/31/2001 | WO2000049557A3 Computer-implemented nucleic acid isolation method and apparatus |
| 05/31/2001 | WO2000042165A3 Bone marrow-specific protein |
| 05/31/2001 | WO2000032196A3 Inhibitors of multidrug transporters |
| 05/31/2001 | WO2000017327A3 Terpene synthases |
| 05/31/2001 | WO2000016101A3 Target analyte sensors utilizing microspheres |
| 05/31/2001 | WO2000012735A3 Transgene assay using stable agrobacterium rhizogenes transformation |
| 05/31/2001 | WO2000006712A3 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 05/31/2001 | WO2000004187A3 Methods and kits for diagnosing and determination of the predisposition of diseases |
| 05/31/2001 | WO1999054479A3 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES |
| 05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
| 05/31/2001 | WO1999024621A9 Methods and compositions for detection of specific nucleotide sequences |
| 05/31/2001 | WO1998059243A8 High density streptavidin supports |
| 05/31/2001 | US20010002420 Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
| 05/31/2001 | US20010002393 Administering to a patient suffering from leiomyoma (fibroid)of uterus an effective dose of an agent which specifically inhibit metalloproteinase selected from stromelysin-2, stromelysin-3 and matrilysin |
| 05/31/2001 | US20010002315 Plasmon resonant particles, methods and apparatus |
| 05/31/2001 | US20010002314 Polynucleotide hybridization probe including nucleoside(s) attached to a molecule such as a metal chelator adapted to cleave a double-stranded nucleic acid through formation of a triple helix; diagnostic and chemotherapeutic uses |
| 05/31/2001 | DE19957638A1 Detecting antibiotics uses thin layer chromatography, a DC plate and bacterial cultures |
| 05/31/2001 | DE19957367A1 Composition for detecting lactoperoxidase in milk, useful for quality control of heat-treated milk, comprises a carrier with peroxidase substrate and iodide to increase sensitivity |
| 05/31/2001 | DE19957320A1 Dynamic sequencing of nucleic acid by hybridization, useful e.g. for research or detecting mutations, includes several hybridization cycles using progressively longer probes |
| 05/31/2001 | DE19957319A1 Detecting analytes in a sample uses determination cycles using immobilized receptors |
| 05/31/2001 | DE19956820A1 Spezies-spezifischer Nachweis von Nukleinsäuren mittels eines Analyseelementes Species-specific detection of nucleic acids by means of an analysis element |
| 05/31/2001 | DE19956686A1 Neue für die Gene sucC und sucD codierende Nukleotidsequenzen New codes for genes sucC and sucD nucleotide sequences |
| 05/31/2001 | DE19956131A1 Neue für das pfk-Gen codierende Nukleotidsequenzen New coding for the pfk gene nucleotide sequences |
| 05/31/2001 | DE19955303A1 Test von Mikroorganismen Test of microorganisms |
| 05/31/2001 | DE19950262A1 Determining phagocytosis defects in patient blood samples, comprises using flow cytometry, yeast cell suspensions and fluorescence |
| 05/31/2001 | CA2422429A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |